Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis (Q36058116)

11 August 2017

1 reference

title

Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis (English)

1 reference

11 August 2017

1 reference

1 reference

Border WA

1

1 reference

11 August 2017

Noble NA

2

1 reference

11 August 2017

Yamamoto T

3

1 reference

11 August 2017

Tomooka S

4

1 reference

11 August 2017

Kagami S

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 March 1992

1 reference

11 August 2017

1 reference

11 August 2017

volume

41

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

566-570

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

11 August 2017

1 reference

7 January 2021

New perspectives in cell adhesion: RGD and integrins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

"Matrix algebra" heals life's wounds

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

Distinguishing minimal-change disease from mesangial disorders

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

Structural-functional relationships in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

Transforming growth factor-beta regulates production of proteoglycans by mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

What distinguishes tenascin from fibronectin?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

Proteoglycans as modulators of growth factor activities

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.83

7 January 2021

Identifiers

DOI

10.1038/KI.1992.83

1 reference

11 August 2017

1 reference